|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,350 KRW | -0.47% |
|
+3.25% | +4.10% |
Bukwang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was KRW 4,904.79 million compared to KRW 2,120.42 million a year ago. Basic loss per share from continuing operations was KRW 83 compared to KRW 39 a year ago.
Diluted loss per share from continuing operations was KRW 83 compared to KRW 39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.10% | 321M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
BUKWANG PHARMACEUTICAL CO., LTD. 
